TPD52L2

Chr 20

TPD52 like 2

Also known as: D54, TPD54

The protein is a member of the tumor protein D52-like family that forms homo- and heteromeric complexes through its N-terminal coiled-coil motif. Mutations in TPD52L2 cause neurodevelopmental disorder with intellectual disability, autism spectrum disorder, and dysmorphic facies, following an autosomal dominant inheritance pattern. This gene is highly constrained against loss-of-function variants (pLI near 1.0), suggesting intolerance to protein-disrupting mutations.

OMIMResearchSummary from RefSeq
MultiplemechanismLOEUF 1.01
Clinical SummaryTPD52L2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
38 unique Pathogenic / Likely Pathogenic· 46 VUS of 106 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.01LOEUF
pLI 0.000
Z-score 1.55
OE 0.56 (0.331.01)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.01Z-score
OE missense 1.00 (0.861.16)
124 obs / 123.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.56 (0.331.01)
00.351.4
Missense OE1.00 (0.861.16)
00.61.4
Synonymous OE0.97
01.21.6
LoF obs/exp: 8 / 14.3Missense obs/exp: 124 / 123.7Syn Z: 0.14
DN
0.86top 5%
GOF
0.81top 10%
LOF
0.1994th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

106 submitted variants in ClinVar

Classification Summary

Pathogenic30
Likely Pathogenic8
VUS46
Likely Benign3
Benign1
Conflicting1
30
Pathogenic
8
Likely Pathogenic
46
VUS
3
Likely Benign
1
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
30
0
30
Likely Pathogenic
0
0
8
0
8
VUS
1
33
12
0
46
Likely Benign
0
3
0
0
3
Benign
0
1
0
0
1
Conflicting
1
Total13750089

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TPD52L2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →